A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)
Clinical trial NCT00758836 · COMPLETED
Trial details
- NCT number
- NCT00758836
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-03
- Primary completion
- 2009-08-24
- Enrollment
- 683
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.